亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

深圳市思科達生物技術有限公司  

專業經營化學標準品,對照品

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:楊森
  • 電話:0755-89218244
  • 郵件:lq@szskerd.com
  • 傳真:0755-28984072
  • QQ:793285927
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 頭孢他啶雜質
頭孢他啶雜質
單價 面議對比
詢價 暫無
發貨 廣東深圳市付款后3天內
品牌 深圳市思科達生物技術有限公司
過期 長期有效
更新 2015-03-04 17:24
 
詳細信息
 ①頭孢他啶雜質A  Ceftazidime Impurity A  CAS NO:1000980-60-8

(2RS,6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate (Δ-2-ceftazidime)

②頭孢他啶雜質B  Ceftazidime Impurity B
 (6R,7R)-7-[[(2E)-2-(2-aminothiazol-4-yl)-2-[(1-carboxy-
1-methylethoxy)imino]acetyl]amino]-8-oxo-3-[(1-
pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-
carboxylate

③頭孢他啶雜質C  Ceftazidime Impurity C   CAS NO:3432-88-0
(6R,7R)-7-amino-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylate

④頭孢他啶雜質E  Ceftazidime Impurity E    CAS NO:102772-66-7
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-[[2-(1,1-dimethylethoxy)-
1,1-dimethyl-2-oxoethoxy]imino]acetyl]
amino]-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[
4.2.0]oct-2-ene-2-carboxylate

⑤頭孢他啶雜質F  Ceftazidime Impurity F    CAS NO:110-86-1
pyridine

⑥頭孢他啶雜質G  Ceftazidime Impurity G    CAS NO:194241-83-3
2-[[[(1Z)-1-(2-aminothiazol-4-yl)-2-[(oxoethyl)amino]-2-
oxoethylidene]amino]oxy]-2-methylpropanoic acid

⑦頭孢他啶雜質H  Ceftazidime Impurity H
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-[(2-methoxy-1,
1-dimethyl-2-oxoethoxy)imino]acetyl]amino]-8-oxo-3-[(1-
pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-
carboxylate

©2025 深圳市思科達生物技術有限公司 版權所有   技術支持:化工網   訪問量:12984  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |